Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04885634
What this trial is testing

Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients

Who this might be right for
Atrial FibrillationOverweight and Obesity
Axel Brandes
Not applicableStudy completedNCT00856700
What this trial is testing

Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
University of Rome Tor Vergata 20
Post-approval studies (Phase 4)Study completedNCT03007329
What this trial is testing

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.

Who this might be right for
Steatosis, LiverType2 Diabetes
Medical University of Vienna 34
Early research (Phase 1)Study completedNCT06648031
What this trial is testing

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Who this might be right for
Type2diabetes
Lexaria Bioscience Corp. 148
Early research (Phase 1)Looking for participantsNCT06576401
What this trial is testing

Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 10
Not applicableNot Yet RecruitingNCT07700030
What this trial is testing

High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)

Who this might be right for
Weight Loss
NYU Langone Health 32
Post-approval studies (Phase 4)Ended earlyNCT02844907
What this trial is testing

Regulation of Insulin Secretion by the GLP-1 Receptor

Who this might be right for
Insulin Secretion
VA Office of Research and Development 6
Not applicableStudy completedNCT03085511
What this trial is testing

High Quality Protein for Assisting With Weight Loss

Who this might be right for
Obesity
Texas Tech University 40
Not applicableStudy completedNCT01341028
What this trial is testing

Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection

Who this might be right for
Morbid Obesity
University of Patras 24
Large-scale testing (Phase 3)Study completedNCT01784965
What this trial is testing

Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

Who this might be right for
Pre-diabetesOlder Adults
Stanford University 69
Not applicableStudy completedNCT01333163
What this trial is testing

GLP-1: Acute Effects on Kidney Function in Healthy Men

Who this might be right for
Kidney Functional
Jeppe Skov 12
Not applicableStudy completedNCT06820047
What this trial is testing

Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study

Who this might be right for
Obesity and Obesity-related Medical Conditions
University of Roma La Sapienza 190
Not applicableNot Yet RecruitingNCT07117721
What this trial is testing

Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
El Katib Hospital 10
Early research (Phase 1)Study completedNCT00931372
What this trial is testing

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 22
Not applicableNot Yet RecruitingNCT07668765
What this trial is testing

GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity

Who this might be right for
Morbid ObesityAnorectal DiseasesDrug-Related Side Effects and Adverse Reactions+2 more
Gazi University 100
Not applicableUnknownNCT04232605
What this trial is testing

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Who this might be right for
Headache, Migraine
Danish Headache Center 43
Not applicableStudy completedNCT00795275
What this trial is testing

Incretin Effect in People With Impaired Fasting Glucose

Who this might be right for
Obesity
University of Colorado, Denver 26
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Post-approval studies (Phase 4)Study completedNCT05574439
What this trial is testing

Young Adults With Early-onset Obesity Treated With Semaglutide

Who this might be right for
Obesity, Adolescent
Signe Torekov 246
Not applicableStudy completedNCT07455630
What this trial is testing

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

Who this might be right for
Obesity & Overweight
TecSalud Investigación Clínica 30
Next Page